A Special Glimpse into Medtronic's Recent Developments in Spine & Biologics Technology

Global Medical Device Podcast · 17 Nov 2021 · 17m · Episode 236

What this episode covers

Carlton Weatherby, Vice President and General Manager of Spine and Biologics at Medtronic, discusses the company's strategy to integrate implants, biologics, navigation, robotics, and data science into a unified ecosystem. He highlights recent product launches like the Catalyst expandable cage and Solera Voyager fixation system, which aim to standardize outcomes in minimally invasive spine surgery (MIS+). Weatherby emphasizes that for startups, success depends on demonstrating a clear clinical value proposition and workflow efficiency to justify acquisition by large players like Medtronic.

Other shows on the same ground, closest first.

  • Being an Engineer · 51m

    S6E19 Stuart Grant | MedTech Innovation

    Dr. Stuart Grant, founder of Archetype MedTech, discusses his 25-year career at Johnson & Johnson and DePuy Synthes before launching his consultancy to help startups navigate medical device development. He details the challenges of securing funding, managing regulatory differences between the EU's MDR and the US FDA, and the strategic importance of narrow clinical indications. Grant also explores future trends in surgical robotics and AI, emphasizing the need for modular platforms and the value of accumulated engineering knowledge.

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

  • The Robot Report Podcast · 1h 09m

    Amazon Astro underwhelms robotics community; Vicarious Surgical CEO Adam Sachs

    Steve Crowe and Mike Oitsman discuss the robotics industry, starting with a recap of Pack Expo where they highlight new automation products from Wyzo and Robotique. They then analyze Amazon's Astro home robot, critiquing its high price, limited functionality, and privacy implications, while noting mixed listener reactions. Finally, Adam Sachs, CEO and founder of Vicarious Surgical, joins to discuss his company's next-generation surgical robotics system, its unique decoupled actuator technology, recent SPAC listing on the NYSE, and the path to FDA clearance.

  • Let's Combinate · 1h 07m

    017 - "Feet First" with Ahmed Zobi

    Ahmed Zobi, Founder and CEO of Syntr Health Technologies, explains how he bootstrapped his company from a university project to FDA 510(k) clearance for the SyntrFuge System, a device that automates the microsizing of adipose tissue for body contouring and wound care. Zobi details the strategic decision to target aesthetics and orthopedics first to generate revenue while pursuing diabetic foot ulcer indications, and describes the intense personal sacrifices made during the grant submission process and the COVID-19 pandemic. He emphasizes the importance of leveraging mentors, conducting customer discovery through the NSF iCorps program, and building a robust quality management system early to navigate regulatory requirements.

  • Being an Engineer · 43m

    S5E15 Derek Harper | The Benefits of Working At A Small Company, & How to Motivate Your Engineering Team

    Derek Harper, a biomedical engineering leader, discusses the career advantages of starting at small startups, such as gaining broad exposure to design, manufacturing, and quality processes, compared to the narrow roles at large medical device corporations. He recounts a specific product failure where a device designed with input from only three lead surgeons was rejected by a larger, high-volume community of users, highlighting the critical need to validate products with diverse customer segments before launch. Harper also details his leadership philosophy of treating teams with respect and sharing the 'why' behind decisions, contrasting it with fear-based management, and highlights emerging trends in biomedical engineering, including biomimetic scaffolds for rotator cuff repairs and brain-implanted chips for ALS patients.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.